Diagnostic tests available for influenza include viral culture, serology, rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays.Influenza diagnostic tests are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative).
MARKET SCOPE
The "Global Molecular Influenza Test Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Molecular Influenza Test market with detailed market segmentation by Test type, Flu Type, end-User, and geography. The report provides key statistics on the market status of the leading Molecular Influenza Test market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on test type, the global Molecular Influenza Test market is segmented into Molecular Diagnostic Tests, Traditional Diagnostic Tests.
- On the basis of Flu Type, the market is segmented into Type A Flu, Type B Flu, Type C Flu.
- Based on End- User, the global Molecular Influenza Test market is segmented into Hospitals, Diagnostic Laboratories, Research and Academic Institutes, Contract Research Organizations (CROs)
MARKET DYNAMICS
Drivers-
- Increasing prevalence of influenza
- Growth in research funding for influenza diagnostics
Restraints-
- Variability in sensitivity and specificity among influenza diagnostic tests
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Molecular Influenza Test market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Molecular Influenza Test market in these regions.
IMPACT OF COVID-19 ON MOLECULAR INFLUENZA TEST MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. However, during a pandemic there are multiple concurrent clinical priorities, including the need to understand the pathophysiology of the disease, optimized patient care and prevention of future infections. The ongoing COVID-19 pandemic has surged the central position of diagnostic testing in outbreak control.
MARKET PLAYERS
The report covers key developments in the Molecular Influenza Test market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Molecular Influenza Test market are anticipated to lucrative growth opportunities in the future with the rising demand for Molecular Influenza Test in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Molecular Influenza Test market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott Laboratories
- Endress+Hauser (Analytik Jena AG)
- Becton, Dickinson and Company
- Biocartis
- bioMérieux Inc
- Danaher Corporation (Cepheid)
- F. Hoffmann-La Roche Ltd
- GenMark Diagnostics, Inc.
- Luminex Corporation
- Meridian Bioscience, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.